Can the eye reveal how the body reacts to nerve stimulation?
NCT ID NCT07746167
First seen Aug 04, 2026 · Last updated Aug 05, 2026 · Updated 1 time
Summary
This observational study looks at how the pupil of the eye reacts to increasing levels of nerve stimulation in healthy adults. Researchers will use a device called AlgometRx to deliver mild electrical stimuli and measure pupil dilation, which may reflect the body's response to pain. The goal is to understand the relationship between stimulation intensity and pupil response, which could inform future pain assessment methods.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- This could help refine how pain is measured objectively, potentially leading to better ways to assess and manage pain without relying solely on self-report.
- What could go wrong
- This is an observational study in healthy volunteers, so results may not apply to people with pain conditions. The measurements may also vary between individuals, limiting generalizability.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Children's National Hospital
RECRUITINGWashington D.C., District of Columbia, 20010, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a common antifungal change how an experimental drug acts?
- Can a new injection help tackle obesity? a safety trial begins
- Will a new pill formula absorb the same? a trial puts it to the test
- Can a new drug tame Alzheimer's? early trial aims to find out
- Could sitting too much alter your nervous system?
- Could a cancer drug alter Metformin's effects? a trial investigates